Methods and compositions comprising a C-terminal Bax peptide
In an aspect, the invention relates to compositions and methods for permeabilizing membranes of cells. In an aspect, the invention relates to compositions and methods for killing cells. In an aspect, the invention relates to compositions and methods of permeabilizing the membranes of cancer cells or microbial cells.
1. A method for treating cancer in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a composition comprising a C-terminal B cell lymphoma-2 (Bcl-2)-associated X protein (Bax) peptide (CT20p peptide) and a pharmaceutically acceptable carrier, wherein the CT20p peptide consists of the amino acid sequence of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, or SEQ ID NO: 4; and wherein the cancer is selected from the group consisting of breast cancer, colorectal cancer, lung cancer, and liver cancer.
2. The method of claim 1 , further comprising administering to the subject an anti-cancer drug.
3. The method of claim 2 , further comprising administering to the subject a chemotherapeutic drug.
4. The method of claim 2 , further comprising administering to the subject a radiosensitizer.
5. The method of claim 1 , wherein the CT20p peptide is administered directly into the cancer.
6. The method of claim 1 , further comprising repeating the administration of the therapeutically effective amount of the composition comprising the CT20p peptide and the pharmaceutically acceptable carrier.
7. The method of claim 1 , wherein the CT20p peptide is encapsulated in a nanoparticle.
8. The method of claim 7 , wherein the nanoparticle is aminated.
9. The method of claim 7 , wherein the nanoparticle is carboxylated.
10. The method of claim 7 , wherein the nanoparticle is a polymeric nanoparticle.
11. The method of claim 10 , wherein the polymeric nanoparticle is a hyperbranched polymeric (HBPE) nanoparticle.